2018-06-09 16:40:00 Sat ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
The Trump administration introduces new tariffs on $50 billion Chinese goods amid the persistent bilateral trade dispute. The tariffs effectively boost costs and prices for American consumers and enterprises. The delivery company FedEx views U.S. tariffs on Chinese goods as *counterproductive to U.S. economic interests*. China counteracts these penalties by imposing 25% retaliatory tariffs on $50 billion U.S. farm imports such as beef, cotton, rice, soy, and wheat. This recent Sino-U.S. trade conflict may herald a new era of much greater trade protectionism.
The U.S. major stock indices S&P 500, Dow, and NASDAQ experience discernible losses in response to the core complex trifecta of Sino-U.S. trade tension, Federal Reserve second interest rate hike, and energy cost momentum. In addition to this negative U.S. stock market return performance, the greenback exhibits much more volatile near-term gyrations in the foreign exchange market. In a putative trade war, there are winners and losers; whereas, everyone suffers in a major trade conflict. Full-scale and all-out tit-for-tat would become a suboptimal approach to resolving the current bilateral trade imbalance.
It is important for each side to refrain from undertaking any unilateral actions to complicate the status quo. Both sides need to consider a better balance between carrots and sticks in addressing the Sino-U.S. trade dilemma.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic
2018-02-15 07:43:00 Thursday ET

Fed minutes reflect gradual interest rate normalization in response to high inflation risk. FOMC members revise up the economic projections made at the Dece
2025-06-28 10:39:00 Saturday ET

Former New York Times science author and Harvard psychologist Daniel Goleman explains why great mental focus serves as a vital mainstream driver of personal
2018-02-27 09:35:00 Tuesday ET

Fed's new chairman Jerome Powell testifies before Congress for the first time. He vows to prevent price instability for U.S. consumers, firms, and finan
2019-05-03 11:29:00 Friday ET

Key tech unicorns blitzscale business niches for better scale economies from Uber and Lyft to Pinterest, Slack, and Zoom. LinkedIn cofounder and serial entr
2023-12-04 12:30:00 Monday ET

Bank leverage and capital bias adjustment through the macroeconomic cycle Abstract We assess the quantitative effects of the recent proposal